NEO - NeoGenomics Non-GAAP EPS of -$0.09 beats by $0.06 revenue of $137.2M beats by $10.81M
2023-05-08 16:26:12 ET
- NeoGenomics press release ( NASDAQ: NEO ): Q1 Non-GAAP EPS of -$0.09 beats by $0.06 .
- Revenue of $137.2M (+17.1% Y/Y) beats by $10.81M .
- Clinical Services revenue increased 16% to $115 million
- Pharma Services revenue increased 22% to $22 million
- 2023 Guidance: Revenue of $555-$565M, Adjusted EBITDA $(22) - $(18)M.
For further details see:
NeoGenomics Non-GAAP EPS of -$0.09 beats by $0.06, revenue of $137.2M beats by $10.81M